Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Local Injection of Submicron Particle Docetaxel is Associated with Tumor Eradication, Reduced Systemic Toxicity and an Immunologic Response in Uro-Oncologic Xenografts.

Maulhardt HA, Hylle L, Frost MV, Tornio A, Dafoe S, Drummond L, Quinn DI, Kamat AM, diZerega GS.

Cancers (Basel). 2019 Apr 24;11(4). pii: E577. doi: 10.3390/cancers11040577.

2.

A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies.

Williamson SK, Johnson GA, Maulhardt HA, Moore KM, McMeekin DS, Schulz TK, Reed GA, Roby KF, Mackay CB, Smith HJ, Weir SJ, Wick JA, Markman M, diZerega GS, Baltezor MJ, Espinosa J, Decedue CJ.

Cancer Chemother Pharmacol. 2015 May;75(5):1075-87. doi: 10.1007/s00280-015-2737-4. Epub 2015 Apr 23.

3.

Angiotensin 1 - 7 stimulation of platelet recovery.

Rodgers KE, Peterson KJ, Maulhardt HA, diZerega GS.

Expert Opin Investig Drugs. 2014 Apr;23(4):551-9. doi: 10.1517/13543784.2014.891015. Epub 2014 Feb 20. Review.

PMID:
24555825

Supplemental Content

Loading ...
Support Center